bluebird bio, Inc. (BLUE)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 202.38M |
| Enterprise value | 331.79M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.91 |
| Price/book (mrq) | 0.91 |
| Enterprise value/revenue | 15.27 |
| Enterprise value/EBITDA | -1.50 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.87 |
| 52-week change 3 | -71.93% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 5.5300 |
| 52-week low 3 | 0.8500 |
| 50-day moving average 3 | 1.1516 |
| 200-day moving average 3 | 2.2597 |
Share statistics
| Avg vol (3-month) 3 | 8.24M |
| Avg vol (10-day) 3 | 7.63M |
| Shares outstanding 5 | 192.74M |
| Implied shares outstanding 6 | 192.74M |
| Float 8 | 108.85M |
| % held by insiders 1 | 0.38% |
| % held by institutions 1 | 59.22% |
| Shares short (30 Apr 2024) 4 | 31.86M |
| Short ratio (30 Apr 2024) 4 | 5.74 |
| Short % of float (30 Apr 2024) 4 | 17.65% |
| Short % of shares outstanding (30 Apr 2024) 4 | 16.53% |
| Shares short (prior month 28 Mar 2024) 4 | 29.75M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1544:1000 |
| Last split date 3 | 05 Nov 2021 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -683.74% |
Management effectiveness
| Return on assets (ttm) | -15.01% |
| Return on equity (ttm) | -47.81% |
Income statement
| Revenue (ttm) | 21.73M |
| Revenue per share (ttm) | 0.21 |
| Quarterly revenue growth (yoy) | 17,353.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -131.77M |
| Net income avi to common (ttm) | -91.17M |
| Diluted EPS (ttm) | -0.6300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 174.29M |
| Total cash per share (mrq) | 1.59 |
| Total debt (mrq) | 303.71M |
| Total debt/equity (mrq) | 136.48% |
| Current ratio (mrq) | 1.55 |
| Book value per share (mrq) | 2.08 |
Cash flow statement
| Operating cash flow (ttm) | -277.48M |
| Levered free cash flow (ttm) | -116.62M |
© 2024 Yahoo. All rights reserved.